| Product Code: ETC7732694 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Bacteriophages Therapy Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Bacteriophages Therapy Market - Industry Life Cycle |
3.4 Japan Bacteriophages Therapy Market - Porter's Five Forces |
3.5 Japan Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 Japan Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Japan Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Japan Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections in Japan |
4.2.2 Growing awareness about bacteriophage therapy as an alternative to antibiotics |
4.2.3 Government initiatives to promote research and development in the field of bacteriophage therapy |
4.3 Market Restraints |
4.3.1 Limited regulatory framework for bacteriophage therapy in Japan |
4.3.2 Challenges in large-scale production and purification of bacteriophages |
4.3.3 Lack of standardized protocols for clinical trials and treatment using bacteriophages |
5 Japan Bacteriophages Therapy Market Trends |
6 Japan Bacteriophages Therapy Market, By Types |
6.1 Japan Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 Japan Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 Japan Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 Japan Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 Japan Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 Japan Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 Japan Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 Japan Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Japan Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Japan Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 Japan Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 Japan Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 Japan Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 Japan Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 Japan Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Japan Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Japan Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 Japan Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Japan Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Japan Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Japan Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Japan Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Japan Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 Japan Bacteriophages Therapy Market Export to Major Countries |
7.2 Japan Bacteriophages Therapy Market Imports from Major Countries |
8 Japan Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials conducted in Japan using bacteriophage therapy |
8.2 Investment in research and development for bacteriophage therapy in Japan |
8.3 Adoption rate of bacteriophage therapy by healthcare facilities in Japan |
9 Japan Bacteriophages Therapy Market - Opportunity Assessment |
9.1 Japan Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 Japan Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Japan Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Japan Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Bacteriophages Therapy Market - Competitive Landscape |
10.1 Japan Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 Japan Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here